Executive Director responsible for HTA leadership and analytics at Novartis. Collaborating across global teams to enhance innovative medicines value and access.
Responsibilities
Provides strategic HTA leadership and serves as an internal expert on HTA positions, methodology (including analytics and other areas), as well as monitoring and providing thought leadership related to HTA trends to drive Novartis HTA strategies to optimize patient access.
Partners within HEOR and the TAs to co-develop and execute prioritized HTA initiatives, including innovative analytics and EU HTA preparedness.
Leads and operationalizes effective, pragmatic and value-adding HTA leadership governance journey within Novartis.
Partners with HEOR/PCO, Access, TAs, Public Affairs/Policy, Regions, Countries to build standards, roadmap, and systems for development and delivery of HTA deliverables.
Enables the development of industry-leading capability and creates new best practices for HTA methodology and data analytics for HTA, including monitoring external best practices for the development and utilization of such methods, and partnering with HEOR professionals on impactful projects for Novartis innovative medicines portfolio.
Drives organizational culture of continuous learning and preparedness in relation to EU HTA and beyond, embedding an HTA mindset across the organisation.
Continues to evolve the EU HTA playbook, internal processes and collaboration from initial learnings.
Strengthens internal JCA preparation processes from development to submission and supports country collaboration in preparation of JCA and bridging to national dossiers.
Provides effective and inspiring enterprise leadership bringing cross-functional partners together under priority HTA initiatives to ensure an aligned strategy internally at Novartis.
Supports the Head of HEOR and PCO to develop and improve new ways of working with a focus on flexibility and efficiency.
Advances HTA excellence within and beyond International HEOR and PCO team.
Builds collaboration and partnerships with external experts to monitor and shape the external environment on methodological topics.
Ensures awareness, understanding and communication of these changes for Novartis innovative medicines portfolio.
Requirements
8+ years of relevant HEOR-related experience
10+ years of pharmaceutical industry experience
Advanced Degree in Health Economics, Epidemiology, Statistics or a related field
Significant global and/or regional experience and/or CPO experience
Subject matter expertise in the areas of HEOR and other approaches to value demonstration.
Experience in evaluating, developing and implementing HTA strategies that addresses payer needs
Considerable experience planning, creating, analyzing and publishing impactful HEOR data/RWD
Proven capability in designing impactful HEOR/PCO, RWE and/or clinical studies for market access.
Proven capability to deploy HEOR methods to support pricing proposals
Strong knowledge of research methodology and statistical methods.
Ability to collaborate with quantitative scientists and external thought-leaders.
HS&E Director managing safety and environmental programs in high - hazard utility construction at NorCal Pipeline. Leading risk mitigation strategies and compliance across multiple regions and divisions.
Lead CVRM Genomic strategy at AstraZeneca’s Centre for Genomics Research, integrating genomics and clinical evidence for therapeutic development. Collaborate with global partners and mentor research teams.
Global Study Director leading clinical studies in haematology at AstraZeneca, focusing on operational excellence and team collaboration. Managing complex drug development from strategy to execution.
Director responsible for innovative education programming at the Legislative Assembly of British Columbia. Developing strategies and performance measures to promote public understanding of B.C.’s parliamentary system.
Executive Director driving strategic initiatives for Oncology R&D portfolio at AstraZeneca. Leading team collaboration and ensuring optimal investment strategies for patient outcomes.
Associate Director of Technology leading engineering teams for Flutter's Global Sports products. Ensuring scalability, reliability, and technology excellence across sports betting platforms.
Assoc Director managing Deal Hub team at Gartner to provide strategic guidance for Sales. Leading relationship building and resolving complex deals for positive business outcomes.
Director of Brand Management for Flushable Wipes at The Honest Company. Leading brand strategy and executing growth plans across retail and eCommerce channels.
Director of Global Congress Strategy responsible for oncology congress planning and execution. Driving strategic congress plans and alignment with medical and commercial teams.